Copyright 2009 Medical News Today Latest Lung Cancer News From Medical News Today. http://www.medicalnewstoday.com/sections/lung_cancer/ admin@medicalnewstoday.com (MNT Admin) editors@medicalnewstoday.com (MNT Editors) en-us Fri, 03 Jul 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/156278.php http://www.medicalnewstoday.com/articles/156278.php A new study by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone the two most prominent sites of lung cancer relapse. The study will be published online in the journal Cell on July 2. Lung Cancer Fri, 03 Jul 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/156232.php http://www.medicalnewstoday.com/articles/156232.php A study published in the July 2009 issue of the Journal of Thoracic Oncology revealed that internet-based lung cancer information was of a higher quality in the United States (US) than in Japan. Dr. Yasushi Goto of the National Cancer Center Hospital in Tokyo and his team of researchers from both the US and Japan evaluated 150 Web sites and determined noticeable differences in the quality and type of information on lung cancer available over the internet in the two countries. Lung Cancer Thu, 02 Jul 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/156110.php http://www.medicalnewstoday.com/articles/156110.php AstraZeneca announced that it has received a licence by the European Medicines Agency (EMEA) for its oral targeted anti-cancer drug, gefitinib, for EGFR (epidermal growth factor receptor-tyrosine kinase) activating mutation positive patients with Non Small Cell Lung Cancer (NSCLC). NSCLC is the most common type of lung cancer and accounts for 80% of all lung cancer cases. Lung Cancer Wed, 01 Jul 2009 06:00:00 PDT http://www.medicalnewstoday.com/articles/156027.php http://www.medicalnewstoday.com/articles/156027.php As scientists continue to decode the human genome and the information becomes publicly available, private companies that offer online genetic testing are multiplying. Scientists at the National Institutes of Health were concerned that perhaps these tests posed a risk. They evaluated responses to an online test among smokers who did or did not have a common genetic variant associated with risk for lung cancer. Lung Cancer Wed, 01 Jul 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/155921.php http://www.medicalnewstoday.com/articles/155921.php Lung Cancer Alliance (LCA) released its updated 2009 Facts About Lung Cancer illustrating again the devastating toll caused by lung cancer. LCA last released its Fact Sheet in 2008. The 2009 Facts About Lung Cancer analyzes the most recent available data from the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Department of Defense (DOD), and Surveillance, Epidemiology and End Results Program (SEER). Lung Cancer Wed, 01 Jul 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/155891.php http://www.medicalnewstoday.com/articles/155891.php The July issue of European Urology, the official journal of the European Association of Urology, features an editorial by Lars Holmberg comparing the results from the European Randomised Study of Screening for Prostate Cancer (ERSPC) with the results from the Prostate, Lung, Colorectal and Prostate / Prostate Cancer Tue, 30 Jun 2009 04:00:00 PDT http://www.medicalnewstoday.com/articles/155826.php http://www.medicalnewstoday.com/articles/155826.php The decision to use expensive cancer therapies that typically produce only a relatively short extension of survival is a serious ethical dilemma in the U.S. that needs to be addressed by the oncology community, according to a commentary published online June 29 in the Journal of the National Cancer Institute. Tito Fojo, M.D., Ph.D., of the Medical Oncology Branch, Center of Cancer Research at the National Cancer Institute, in Bethesda, Md., and Christine Grady, Ph.D. Cancer / Oncology Sat, 20 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/154700.php http://www.medicalnewstoday.com/articles/154700.php Helix BioPharma Corp. (TSX, FSE: HBP) announced that Dr. Heman Chao, chief scientific officer at Helix BioPharma Corp., will be presenting a scientific poster describing L-DOS47 analytical method development findings at the 2009 American Association of Pharmaceutical Scientists ("AAPS") National Biotechnology Conference, which runs from June 21st to 24th at the Washington State Convention and Trade Center in Seattle, Washington. Lung Cancer Wed, 17 Jun 2009 05:00:00 PDT http://www.medicalnewstoday.com/articles/154227.php http://www.medicalnewstoday.com/articles/154227.php Researchers at UCLA's Jonsson Comprehensive Cancer Center, on a quest to find lung cancer stem cells, have developed a unique model to allow further investigation into the cells that many believe may be at the root of all lung cancers. Lung Cancer Wed, 17 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/154094.php http://www.medicalnewstoday.com/articles/154094.php A lung cancer treatment that inhibits nicotine receptors was shown to double survival time in mice, according to Italian researchers. The results of the early phase animal model study were reported in the June 15 issue of the American Journal of Respiratory and Critical Care Medicine. Changes in genes encoding nicotine receptors are strongly associated not only with the tendency to smoke, but with susceptibility to lung cancer. Lung Cancer Wed, 17 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/154095.php http://www.medicalnewstoday.com/articles/154095.php A new lung cancer therapy employing a vaporized viral vector to deliver a cancer-inhibiting molecule directly to lung tissue shows early promise in mouse trials, according to researchers at the Ministry of Education, Science and Technology in Korea. Gene therapy is an area of great promise, but delivery mechanisms, which have included intravenous injection and intratracheal instillation, have proven problematic for effective delivery of genetic therapy to lung tissues. Lung Cancer Wed, 17 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/154129.php http://www.medicalnewstoday.com/articles/154129.php OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review the supplemental New Drug Application (sNDA) for the use of Tarceva® (erlotinib) as a first-line maintenance treatment for patients with advanced non-small cell lung cancer (NSCLC) who have not progressed following first-line treatment with platinum-based chemotherapy. Lung Cancer Wed, 10 Jun 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/153255.php http://www.medicalnewstoday.com/articles/153255.php Statement of Charles D. Connor, American Lung Association President and CEO: The American Lung Association welcomes the Surgeon General's Call to Action to Promote Healthy Homes issued today. We pledge to work to ensure healthy indoor air in homes for everyone. In far too many homes across the United States people breathe air that can make them seriously ill or even threaten their lives. Respiratory / Asthma Wed, 10 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/153174.php http://www.medicalnewstoday.com/articles/153174.php A lung cancer treatment that inhibits nicotine receptors was shown to double survival time in mice, according to Italian researchers. The results of the early phase animal model study were reported in the June 15 issue of the American Journal of Respiratory and Critical Care Medicine. Changes in genes encoding nicotine receptors are strongly associated not only with the tendency to smoke, but with susceptibility to lung cancer. Lung Cancer Tue, 09 Jun 2009 07:00:00 PDT http://www.medicalnewstoday.com/articles/153154.php http://www.medicalnewstoday.com/articles/153154.php A new lung cancer therapy employing a vaporized viral vector to deliver a cancer-inhibiting molecule directly to lung tissue shows early promise in mouse trials, according to researchers at the Ministry of Education, Science and Technology in Korea. Gene therapy is an area of great promise, but delivery mechanisms, which have included intravenous injection and intratracheal instillation, have proven problematic for effective delivery of genetic therapy to lung tissues. Lung Cancer Tue, 09 Jun 2009 06:00:00 PDT http://www.medicalnewstoday.com/articles/153147.php http://www.medicalnewstoday.com/articles/153147.php A chemotherapy drug that is supposed to help save cancer patients' lives, instead resulted in life-threatening and sometimes fatal allergic reactions. Lung Cancer Fri, 05 Jun 2009 07:00:00 PDT http://www.medicalnewstoday.com/articles/152800.php http://www.medicalnewstoday.com/articles/152800.php More than one kind of stem cell is required to support the upkeep and repair of the lungs, according to a new study published in the journal Cell Stem Cell. Scientists at Duke University Medical Center painstakingly followed and counted genetically labeled cells in the mouse lung for over a year, under differing conditions, to learn more about natural renewal and healing processes. Lung Cancer Fri, 05 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/152611.php http://www.medicalnewstoday.com/articles/152611.php Results from a Phase III study presented at the American Society for Clinical Oncology (ASCO) Annual Meeting in Orlando, Florida today show that patients with advanced non-small cell lung cancer (NSCLC) who received erlotinib (Tarceva®) as first-line maintenance treatment benefited from a significant (29%) improvement in the time they lived without the disease advancing, compared with those who received placebo1. Lung Cancer Fri, 05 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/152622.php http://www.medicalnewstoday.com/articles/152622.php Ray Berkelbach is taking long walks three times a day just a couple weeks after having lung surgery. The 68-year-old retiree from Punta Gorda underwent robotic surgery at Moffitt Cancer Center to remove a cancerous part of his lung. His was the first lung procedure in the Tampa Bay area that used the robot-assisted da Vinci surgical system. "This took nothing out of me. I've had no pain," said Berkelbach. "People look at me and can't believe I just had a lung operation. Lung Cancer Thu, 04 Jun 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/152519.php http://www.medicalnewstoday.com/articles/152519.php It's common knowledge that smoking raises risks of lung cancer. And yet researchers haven't known whether continued smoking by lung cancer patients would increase the risk of the cancer's spread. Researchers at West Virginia University studying the relationship between death rates from lung cancer and how much a person smoked have found that smoking intensity in fact predicts how the disease will progress. Lung Cancer Thu, 04 Jun 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/152501.php http://www.medicalnewstoday.com/articles/152501.php A national Radiation Therapy Oncology Group (RTOG) study led by a Medical College of Wisconsin Cancer Center physician at Froedtert Hospital in Milwaukee has found that a course of radiation therapy to the brain after treatment for locally advanced non-small cell lung cancer reduced the risk of metastases to the brain within the first year after treatment. The study was presented at the American Society of Clinical Oncology annual meeting in Orlando, June 1. Lung Cancer Thu, 04 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/152437.php http://www.medicalnewstoday.com/articles/152437.php Data from the Phase III ZODIAC1 study in advanced non-small cell lung cancer patients, with the investigational drug vandetanib, were presented today at the American Society of Clinical Oncology (ASCO) meeting in Orlando. Lung Cancer Thu, 04 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/152442.php http://www.medicalnewstoday.com/articles/152442.php Bayer HealthCare AG and Onyx Pharmaceuticals, Inc. today announced that the companies have begun enrolling patients in an international Phase III trial to evaluate Nexavar® (sorafenib) tablets in patients with non-squamous non-small cell lung cancer (NSCLC) who have failed two or three previous treatments. Lung Cancer Wed, 03 Jun 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/152401.php http://www.medicalnewstoday.com/articles/152401.php Eli Lilly and Company (NYSE: LLY) announced that the European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of ALIMTA® (pemetrexed for injection) as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. Lung Cancer Tue, 02 Jun 2009 07:00:00 PDT http://www.medicalnewstoday.com/articles/152263.php http://www.medicalnewstoday.com/articles/152263.php ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced that it presented final data from a Phase I study of palifosfamide (ZymafosTM) in combination with doxorubicin at the 45th Annual American Society of Clinical Oncology (ASCO) meeting held in Orlando, FL, May 29th to June 2nd. Lung Cancer